Financials data is unavailable for this security.
View more
Year on year Shanghai Titan Scientific Co Ltd had net income fall -41.85% from 124.81m to 72.57m despite a 6.20% increase in revenues from 2.61bn to 2.77bn. An increase in the selling, general and administrative costs as a percentage of sales from 10.56% to 12.23% was a component in the falling net income despite rising revenues.
| Gross margin | 17.97% |
|---|---|
| Net profit margin | 0.23% |
| Operating margin | 0.34% |
| Return on assets | 0.14% |
|---|---|
| Return on equity | 0.37% |
| Return on investment | 0.20% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at Shanghai Titan Scientific Co Ltd fell by 352.03m. Cash Flow from Financing totalled 244.03m or 8.81% of revenues. In addition the company used 124.53m for operations while cash used for investing totalled 471.57m.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 16.91 |
|---|---|
| Tangible book value per share | 14.75 |
More ▼
Balance sheet in CNYView more
| Current ratio | 2.13 |
|---|---|
| Quick ratio | 1.41 |
| Total debt/total equity | 0.5398 |
|---|---|
| Total debt/total capital | 0.3441 |
More ▼
Growth rates in CNY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -30.00% and -45.06%, respectively. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
| Div yield(5 year avg) | -- |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 162.07% |
| EPS growth(5 years) | -6.27 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -90.04 |
More ▼
